首页 > 市场调查报告书 > 製药

以基因为基之药物开发

市场调查报告书

商品编码

1547567

全球全基因组合成市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Whole Genome Synthesis Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 117 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球全基因组合成市场需求预计将从 2023 年的 44 亿美元达到近 357.7 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 26.21%。

全基因组合成涉及利用工程技术重新设计生物体以实现有价值的目的，以产生新的能力。专家使用软体设计他们产生的遗传安排并将其带入有机体，透过这种方式重建微生物以完成所需的工作，例如製造新药物。全基因组合成是一套强大的分子工具，可帮助合成生物学家组装不同大小和规模的 DNA。

市场动态

全球全基因组合成市场正处于新兴阶段。在预测期内，市场将出现蓬勃发展。不断增长的可持续性、不断增加的疾病负担以及传统研究的耗时过程是推动全基因组合成需求的关键因素。全基因组合成是合成生物学的一个蓬勃发展的领域。对蛋白质疗法和个人化医疗的需求不断增加，以及合成药物和疫苗的研究不断增加，预计将创造充足的市场成长机会。蓬勃发展的创新、不断增加的研发资金以及不断增长的合成生物学倡议是有助于创造收入的其他重要因素。随着高效、低成本基因组合成和组装技术的发展，合成基因组学很快就会成为研究途径的普遍现象，从而促进市场成长。然而，缺乏熟练的专家和对技术的适应性差可能会阻碍市场的成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球全基因组合成市场的每个细分市场进行了包容性评估。全基因组合成产业的成长和趋势为这项研究提供了整体方法。

市场区隔

全基因组合成市场报告的这一部分提供了有关国家和区域层面细分市场的详细资料，从而帮助策略家确定相应产品或服务的目标人口统计数据以及即将到来的机会。

按申请

化学及特殊化学品
生物技术
製药
农业
部门

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲全基因组合成市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。全基因组合成市场的主要参与者包括 J. Craig Venter Institute、Ansa Biotechnologies、Twist Bioscience、Integrated DNA Technologies、Icon Genetics。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 7 章：全基因组合成公司的竞争格局

全基因组合成市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 8 章：公司简介

顶级公司市占率分析
市场集中度
J. Craig Venter Institute

公司概况
公司收入
产品
最新动态

Ansa Biotechnologies

公司概况
公司收入
产品
最新动态

Twist Bioscience

公司概况
公司收入
产品
最新动态

Integrated DNA Technologies

公司概况
公司收入
产品
最新动态

Icon Genetics

公司概况
公司收入
产品
最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR11214801

The global demand for Whole Genome Synthesis Market is presumed to reach the market size of nearly USD 35.77 Billion by 2032 from USD 4.4 Billion in 2023 with a CAGR of 26.21% under the study period 2024-2032.

Whole-genome synthesis involves redesigning organisms for valuable purposes with engineering techniques for making new abilities. Specialists use software to design hereditary arrangements that they produce and bring into an organism, in this way reconstructing the microbe to accomplish wanted work like making new medication. Whole-genome synthesis is a robust set of molecular tools that helps synthetic biologists to assemble DNA of different sizes and scales.

MARKET DYNAMICS

The global whole-genome synthesis market is at its emerging stage. The market will witness booming growth during the forecast period. Growing sustainability, mounting disease burden, and the time-consuming process of traditional research are key factors driving the demand for whole-genome synthesis. Whole-genome synthesis is a booming field of synthetic biology. Increasing demand for protein therapeutics and personalized medicine and rising research in synthetic drugs and vaccines is estimated to create ample market growth opportunities. Booming innovations, rising R&D funding, and growing initiatives in synthetic biology are other significant factors contributing to revenue generation. Synthetic genomics will soon become commonplace to research pathways with the development of high-efficient, low-cost genome synthesis and assembly technologies, contributing to increased market growth. However, a lack of skilled specialists and poor adaptability to technology will probably hinder the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Whole Genome Synthesis. The growth and trends of Whole Genome Synthesis industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Whole Genome Synthesis market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Application

Chemical & Specialty Chemical
Biotechnology
Pharmaceutical
Farming
Sector

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Whole Genome Synthesis market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Whole Genome Synthesis market include J. Craig Venter Institute, Ansa Biotechnologies, Twist Bioscience, Integrated DNA Technologies, Icon Genetics. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. WHOLE GENOME SYNTHESIS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Application
- 3.7.2 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL WHOLE GENOME SYNTHESIS MARKET ANALYSIS BY APPLICATION

5.1. Overview By Application
5.2. Historical and Forecast Data Analysis By Application
5.3. Chemical & Specialty Chemical Historic and Forecast Sales By Regions
5.4. Biotechnology Historic and Forecast Sales By Regions
5.5. Pharmaceutical Historic and Forecast Sales By Regions
5.6. Farming Historic and Forecast Sales By Regions
5.7. Sector Historic and Forecast Sales By Regions

6. GLOBAL WHOLE GENOME SYNTHESIS MARKET ANALYSIS BY GEOGRAPHY

6.1. Regional Outlook
6.2. Introduction
6.3. North America Sales Analysis
- 6.3.1 Overview, Historic and Forecast Data Sales Analysis
- 6.3.2 North America By Segment Sales Analysis
- 6.3.3 North America By Country Sales Analysis
- 6.3.4 United States Sales Analysis
- 6.3.5 Canada Sales Analysis
- 6.3.6 Mexico Sales Analysis
6.4. Europe Sales Analysis
- 6.4.1 Overview, Historic and Forecast Data Sales Analysis
- 6.4.2 Europe By Segment Sales Analysis
- 6.4.3 Europe By Country Sales Analysis
- 6.4.4 United Kingdom Sales Analysis
- 6.4.5 France Sales Analysis
- 6.4.6 Germany Sales Analysis
- 6.4.7 Italy Sales Analysis
- 6.4.8 Russia Sales Analysis
- 6.4.9 Rest Of Europe Sales Analysis
6.5. Asia Pacific Sales Analysis
- 6.5.1 Overview, Historic and Forecast Data Sales Analysis
- 6.5.2 Asia Pacific By Segment Sales Analysis
- 6.5.3 Asia Pacific By Country Sales Analysis
- 6.5.4 China Sales Analysis
- 6.5.5 India Sales Analysis
- 6.5.6 Japan Sales Analysis
- 6.5.7 South Korea Sales Analysis
- 6.5.8 Australia Sales Analysis
- 6.5.9 South East Asia Sales Analysis
- 6.5.10 Rest Of Asia Pacific Sales Analysis
6.6. Latin America Sales Analysis
- 6.6.1 Overview, Historic and Forecast Data Sales Analysis
- 6.6.2 Latin America By Segment Sales Analysis
- 6.6.3 Latin America By Country Sales Analysis
- 6.6.4 Brazil Sales Analysis
- 6.6.5 Argentina Sales Analysis
- 6.6.6 Peru Sales Analysis
- 6.6.7 Chile Sales Analysis
- 6.6.8 Rest of Latin America Sales Analysis
6.7. Middle East & Africa Sales Analysis
- 6.7.1 Overview, Historic and Forecast Data Sales Analysis
- 6.7.2 Middle East & Africa By Segment Sales Analysis
- 6.7.3 Middle East & Africa By Country Sales Analysis
- 6.7.4 Saudi Arabia Sales Analysis
- 6.7.5 UAE Sales Analysis
- 6.7.6 Israel Sales Analysis
- 6.7.7 South Africa Sales Analysis
- 6.7.8 Rest Of Middle East And Africa Sales Analysis

7. COMPETITIVE LANDSCAPE OF THE WHOLE GENOME SYNTHESIS COMPANIES

7.1. Whole Genome Synthesis Market Competition
7.2. Partnership/Collaboration/Agreement
7.3. Merger And Acquisitions
7.4. New Product Launch
7.5. Other Developments

8. COMPANY PROFILES OF WHOLE GENOME SYNTHESIS INDUSTRY

8.1. Top Companies Market Share Analysis
8.2. Market Concentration Rate
8.3. J. Craig Venter Institute
- 8.3.1 Company Overview
- 8.3.2 Company Revenue
- 8.3.3 Products
- 8.3.4 Recent Developments
8.4. Ansa Biotechnologies
- 8.4.1 Company Overview
- 8.4.2 Company Revenue
- 8.4.3 Products
- 8.4.4 Recent Developments
8.5. Twist Bioscience
- 8.5.1 Company Overview
- 8.5.2 Company Revenue
- 8.5.3 Products
- 8.5.4 Recent Developments
8.6. Integrated DNA Technologies
- 8.6.1 Company Overview
- 8.6.2 Company Revenue
- 8.6.3 Products
- 8.6.4 Recent Developments
8.7. Icon Genetics
- 8.7.1 Company Overview
- 8.7.2 Company Revenue
- 8.7.3 Products
- 8.7.4 Recent Developments